Treatment of sleep dysfunction and psychiatric disorders.

Treatment of sleep dysfunction and psychiatric disorders. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of sleep dysfunction and psychiatric disorders. Abstract Text:

Philip M Becker,

Patients with neurologic disorders commonly experience sleep dysfunction and psychiatric disorders. The most common sleep dysfunction is insomnia, which is a primary symptom in 30% to 90% of psychiatric disorders. Insomnia and fatigue are prominent symptoms of anxiety disorders and major depression, including patients who are treated but have residual symptoms. Anxiety and depressive disorders account for 40% to 50% of all cases of chronic insomnia. It is also recognized that primary insomnia and other primary sleep disorders produce symptoms that are similar to those reported by patients with psychiatric disorders. A clinician must judge whether sleep deprivation causes mood disturbance or whether depressive or anxiety disorder represents the primary reason for sleep dysfunction. When insomnia is comorbid with mild to moderate depression, therapy should begin with bedtime dosing of sedating antidepressants such as mirtazapine, nefazodone, or tricyclic antidepressants, which are preferred because of their sedative effects, although side effects may limit their usefulness. Intervention for chronic insomnia is similar in nonpsychiatric and psychiatric patients. Behavioral therapies, particularly cognitive behavioral therapy, and lifestyle changes show significant long-term efficacy as treatments for chronic insomnia. Sedative hypnotic agents are the most studied agents to treat insomnia, particularly those that are active through the benzodiazepine receptor-GABA complex, such as benzodiazepines, eszopiclone, zaleplon, and zolpidem. The new melatonin-receptor agonist ramelteon has not yet been studied in psychiatric patients. Prescription of adjunctive trazodone 50 to 150 mg is a common clinical practice to treat comorbid insomnia during antidepressant therapy, but published data are surprisingly limited when considered against the frequent usage of trazodone. Although there has been insufficient research on the use of atypical antipsychotic agents in severe insomnia, psychiatrists use quetiapine, olanzapine, or other agents to lessen agitation that disrupts sleep onset or maintenance. When insomnia or hypersomnia continues even as mood, anxiety, or thought disorders improve with standard therapy, the physician should consider the potential presence of underlying sleep disorders.

Treatment of sleep dysfunction and psychiatric disorders. Publishing Authors By Initials

PM Becker,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of sleep dysfunction and psychiatric disorders. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current treatment options in neurology

VOLUME: 8

Page Numbers: 367-75

Journal Abbreviation:

ISSN: 1092-8480

DAY: 11

MONTH: Sep

YEAR: 2006

Treatment of sleep dysfunction and psychiatric disorders. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815940

Treatment of sleep dysfunction and psychiatric disorders. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Treatment of sleep dysfunction and psychiatric disorders. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of sleep dysfunction and psychiatric disorders.

AFFILIATION: Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5477 Glen Lakes Drive, #100, Dallas, TX 75234, USA. pbecker@sleepmed.com.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Treat Options Neurol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of sleep dysfunction and psychiatric disorders Related Publications

• A combined intradural presigmoid-transtransversarium-transcondylar approach to the whole clivus and anterior craniospinal region: anatomic study.
• A trivial sign to rare genetic disorder.
• Attending to a misoriented word causes the eyeball to rotate in the head.
• BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction.
• Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.
• Dial-a-doc gets boost. JCAHO issues first official telemedicine endorsement.
• Effects of Plant Bioregulators on Valepotriate Production of Cell Suspension Cultures of Valeriana wallichii and Fedia cornucopiae.
• Evidence-bases medicine: What is the evidence?
• Expression of the zebrafish recognition molecule F3/F11/contactin in a subset of differentiating neurons is regulated by cofactors associated with LIM domains.
• Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease.
• HPCL Separation and Quantitative Determination of Valepotriates from Valeriana kilimandascharica.
• Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
• Intensive caring. He's a physician-lawyer-consultant, and his patients are typically small hospitals on life support.
• Methylated flavonoid-aglycones from "matricariae flos".
• Middle cranial fossa transtemporal approach to the intrapetrous internal carotid artery.
• Migration, cultural bereavement and cultural identity.
• PlexinA3 restricts spinal exit points and branching of trunk motor nerves in embryonic zebrafish.
• Redox-induced changes in flavin structure and roles of flavin N(5) and the ribityl 2'-OH group in regulating PutA--membrane binding.
• Reinvestigation of the phenylpropanoids from the roots of pimpinella species.
• The CARI guidelines. Kidney stones: cystine stones.
• The CARI guidelines. Kidney stones: uric acid stones.
• The first extracellular loop of the Saccharomyces cerevisiae G protein-coupled receptor Ste2p undergoes a conformational change upon ligand binding.
• The prevalence of microalbuminuria and ECG left ventricular hypertrophy in hypertensive patients in private practices in South Africa.
• The role of friendship in the lives of male and female adolescents: does diabetes make a difference?
• Treatment of sleep dysfunction and psychiatric disorders.
• Unmitigated communion and health among adolescents with and without diabetes: the mediating role of eating disturbances.
• Vascular access outcomes and medication use: a USRDS study.
• Ventricular volume and dementia progression in the Cardiovascular Health Study.
• Voluntary ethanol drinking in mice and ethanol concentrations in the nucleus accumbens.
• [In Process Citation]